Assessment of the dynamics of focal changes after the intensive phase of treatment in patients with sensitive and resistant pulmonary tuberculosis

M. Gumeniuk (Kyiv, Ukraine), M. Lynnyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), V. Ignatieva (Kyiv, Ukraine), O. Denysov (Kyiv, Ukraine)

Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session: Multidrug-resistant tuberculosis
Session type: E-poster session
Number: 467
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Gumeniuk (Kyiv, Ukraine), M. Lynnyk (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), V. Ignatieva (Kyiv, Ukraine), O. Denysov (Kyiv, Ukraine). Assessment of the dynamics of focal changes after the intensive phase of treatment in patients with sensitive and resistant pulmonary tuberculosis. 467

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relation between level of acute phase proteins and efficiency of treatment in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

Clinical characteristic of the patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 661s
Year: 2007

The pharmacotherapy options for the intensive treatment phase in patients with primarily diagnosed pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003

Effectiveness of the intensive phase of chemotherapy in pulmonary TB patients with primary drug resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 290s
Year: 2006

Are there differences between radiological changes and two acute phase proteins in patients with pulmonary tuberculosis?
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002

Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017

Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003

Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

The clinical features and treatment results of cases with multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004


The dynamics of reactants of acute phase of inflammation in adolescents with newly detected drug-resistant TB during the treatment
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008

Effects of complex treatment with izofon of a pulmonary tuberculosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004

A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Dynamics of morphological changes at multi drug resistant experimental lung tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 663s
Year: 2007

Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy
Source: Eur Respir J 2005; 26: Suppl. 49, 192s
Year: 2005

Efficiency of intravenous treatment with levofloxacin in patients with MDR pulmonary tuberculosis in the intensive phase of chemotherapy
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Treatment results and follow up of patients with chronic multidrug resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Evaluation of characteristics and treatment results of patients treated as multidrug resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012